About Us

Firefly Innovations LLC, creates highly antimicrobial, environmentally friendly, and patented antimicrobial and 3D printing technologies derived from nature.

Our mission is to advance the wound care market and address the unmet needs of patients through eco-friendly alternatives to silver dressing. 

Our patented antimicrobial technology platform disrupts the current standard of care for treating wounds in the inflammatory phase:

  • More effective (2 logs) at disrupting biofilms than silver

  • Derived from natural ingredients to address the growing concerns raised by silver dressing waste

  • Absorbs the characteristic odor of chronic wounds, improving the comfort of patients and caregivers

Our 3D printing technology aims at improving dressing ease of use with better tensile strength, fluid management, and mechanical action than the standard of care. 

Firefly Innovations, LLC addresses a $1.5 billion market with several unmet needs

All wounds undergo 4 common stages of wound healing:

4

Remodeling

Freshly healed epidermis

Freshly

healed

dermis

2

Scab

Inflammation

Fibroblast

Macrophage

Blood vessel

Bacterial infections maintain wounds in the inflammation phase and prevent the wound healing process. They have to be treated locally by antimicrobial dressing.

3

Proliferation

Proliferating

Fibroblast

Subcutaneous fat

1

Hemostasis

Blood Clot

 Every year 6.5 million people suffer from chronic wounds in the U.S.

Annual cost to the U.S. healthcare 
system from chronic wounds

$28B

Global antimicrobial dressing

market size and split by technology

SILVER

OTHERS

70%

30%

$1.5B

Antimicrobial Market Size, Global, 2018

Unmet needs 

by current antimicrobial dressings

They are typically not efficient at treating bacterial biofilms or require a high dose of antimicrobial agents in order to be effective.

They can prevent wound healing by destroying healthy tissues and/or preventing cell proliferation and migration.

The waste from silver dressings is harmful to the environment and raise environmental concerns particularly in the EU.

Wounds often produce a characteristic odor due to the bacterial colonization. This reduces the patient quality of life, leading to social isolation and to discomfort for healthcare professionals and other care givers.

Source: Frost and Sullivan, 2014, Markets and Market, 2017, World Alliance for Wound and Lymphedema Care, Alira Health analysis